Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Valsartan reduces the incidence of atrial fibrillation in the patients with heart failure in the Val-HeFT Trial — Aldo Maggioni (2003) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Valsartan reduces the incidence of atrial fibrillation in the patients with heart failure in the Val-HeFT Trial
Shared by
Aldo Maggioni
Valsartan reduces the incidence of atrial fibrillation in the patients with heart failure in the Val-HeFT Trial
Article
2003
en
Authors
Aldo Maggioni
Related publications
Article
2005
Valsartan Reduces the Incidence of Atrial Fibrillation in Patients With Heart Failure: Results From the Valsartan Heart Failure Trial (Val-HeFT)
Aldo Maggioni
,
Roberto Latini
,
Peter E. Carson
Article
2005
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
Aldo Maggioni
,
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Roberto Latini
,
Peter E. Carson
,
Steven Singh
,
Simona Barlera
,
Robert Glazer
,
Serge Masson
,
E Cerè
,
Gianni Tognoni
,
Jay N. Cohn
Article
2004
Effect of Valsartan Added to Background ACE Inhibitor Therapy in Patients with Heart Failure: Results from Val-HeFT
Henry Krum
,
Peter E. Carson
,
Csaba Farsang
,
Aldo Maggioni
,
Robert Glazer
,
Nora Aknay
,
YannTong Chiang
,
Jay N. Cohn
Article
2010
Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)
Serge Masson
,
Scott D. Solomon
,
Laura Angelici
,
Roberto Latini
,
Inder S. Anand
,
Margaret F. Prescott
,
Aldo Maggioni
,
Gianni Tognoni
,
Jay N. Cohn
Article
2003
1928 The prognostic value of body mass index in patients with heart failure: data from the Val-HeFT trial
Aldo Maggioni
Discussion(0)
No comments yet. Be the first to comment.